NCT07335497
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07335497
Title CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors (ASCEND)
Acronym ASCEND
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Crescent Biopharma, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Clinical Study Site Denver Colorado 80218 United States Details
Clinical Study Site Orlando Florida 32827 United States Details
Clinical Study Site Sarasota Florida 34236 United States Details
Clinical Study Site Nashville Tennessee 37203 United States Details
Clinical Study Site Dallas Texas 75230 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field